Intervention
tamoxifen
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 23 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
23 shownOmission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving SurgeryNCT07762885 · 2026-07-01
RECRUITINGEffect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving TamoxifenNCT07145827 · 2024-01-02
COMPLETEDDecision Aids for Tamoxifen Treatment in Breast Cancer PatientsNCT02488603 · 2015-08-01
UNKNOWNBreast Cancer, Sexuality and Black CohoshNCT02467686 · 2014-01-01
UNKNOWNTamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast CancerNCT01124695 · 2011-01-07
COMPLETEDBiological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+NCT01220076 · 2009-09-01
COMPLETEDEvaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young WomenNCT00912548 · 2009-05-01
UNKNOWNA Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast CancerNCT00728949 · 2008-08-01
COMPLETEDZoladex Plus Tamoxifen in Breast CancerNCT00827307 · 2008-06-01
COMPLETEDGenetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph NodesNCT00433589 · 2007-02-01
COMPLETEDHOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.NCT00412022 · 2004-03-01
UNKNOWNTriptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast CancerNCT00066703 · 2003-11-03
COMPLETEDPremenopausal Endocrine Responsive Chemotherapy TrialNCT00066807 · 2003-08-01
TERMINATEDExemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast CancerNCT00279448 · 2002-01-01
COMPLETEDExemestane (Aromasine) + Tamoxifen - Breast Neo-AdjuvantNCT00919399 · 2002-01-01
COMPLETEDCognition in the Study of Tamoxifen and RaloxifeneNCT00687102 · 2001-10-01
COMPLETEDSU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast CancerNCT00005822 · 2000-04-01
COMPLETEDTamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic AcidNCT00295646 · 1999-06-01
COMPLETEDPhase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)NCT00590785 · 1996-08-13
COMPLETEDTamoxifen StudyNCT00000529 · 1992-05-01
COMPLETEDTrastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast CancerNCT00053339
WITHDRAWNStudy of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer PatientsNCT01169792
COMPLETEDPhase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.NCT00034125
COMPLETEDCommon conditions
Breast Cancer11Breast Neoplasms4Stage IV Breast Cancer2Aging1Antineoplastic Agents1Cardiovascular Diseases1Cognition1Coronary Disease1Cyclophosphamide1Doxorubicin1Ductal Carcinoma In Situ, DCIS1Endometrial Hyperplasia and Endometrial Cancers1Endometrium1Estrogen1Heart Diseases1High Risk1Hypertension1Lipemia1Mammography1Metastatic Breast Cancer1Myocardial Ischemia1Non Metastatic Breast Cancer1Positive Nodes1Recurrent Breast Cancer1Sexuality1
Leading sponsors
Eli Lilly and Company
2
ETOP IBCSG Partners Foundation
2
Alliance for Clinical Trials in Oncology
1
Austrian Breast & Colorectal Cancer Study Group
1
Case Comprehensive Cancer Center
1
ECOG-ACRIN Cancer Research Group
1
European Organisation for Research and Treatment of Cancer - EORTC
1
Fudan University
1
Institut Cancerologie de l'Ouest
1
Institut Claudius Regaud
1
Irmandade da Santa Casa de Misericordia de Sao Paulo
1
Korean Breast Cancer Study Group
1
National Cancer Center, Korea
1
National Cancer Institute (NCI)
1
National Cancer Institute, Naples
1
Trial status mix
COMPLETED16
UNKNOWN4
RECRUITING1
TERMINATED1
WITHDRAWN1
Phase mix
PHASE313
PHASE24
NA3
PHASE11
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.